Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Newly Diagnosed Multiple Myeloma

被引：8

作者：

White, Darrell J. ^{[1
,2
]}

Lentzsch, Suzanne ^{[3
]}

Gasparetto, Cristina ^{[4
]}

Bahlis, Nizar ^{[5
]}

Chen, Christine I. ^{[6
]}

Lipe, Brea C. ^{[7
]}

Schiller, Gary J. ^{[8
]}

Tuchman, Sascha A. ^{[9
]}

Sutherland, Heather J. ^{[10
]}

Kotb, Rami ^{[11
]}

Leblanc, Richard ^{[12
]}

Sebag, Michael ^{[13
]}

Venner, Christopher P. ^{[14
]}

Callander, Natalie Scott ^{[15
]}

Bensinger, William I. ^{[16
]}

Sheehan, Heidi ^{[17
]}

Chai, Yi ^{[17
]}

Kai, Kazuharu ^{[17
]}

Shah, Jatin ^{[17
]}

Shacham, Sharon ^{[17
]}

Kauffman, Michael G. ^{[17
]}

Baljevic, Muhamed ^{[18
]}

机构：

[1] Dalhousie Univ, Halifax, NS, Canada

[2] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[3] Colombia Univ, New York, NY USA

[4] Duke Univ, Med Ctr, Durham, NC USA

[5] Southern Alberta Canc Res Inst, Calgary, AB, Canada

[6] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada

[7] Univ Rochester, Med Coll, Rochester, NY USA

[8] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[9] Univ N Carolina, Chapel Hill, NC 27515 USA

[10] Vancouver Gen Hosp, Vancouver, BC, Canada

[11] Canc Care Manitoba, Winnipeg, MB, Canada

[12] Hop Maison Neuve Rosemont, Montreal, PQ, Canada

[13] Royal Victoria Hosp, Montreal, PQ, Canada

[14] Cross Canc Inst, Edmonton, AB, Canada

[15] Univ Wisconsin, Carbone Cancer Center, Madison, WI USA

[16] Swedish Canc Inst, Myeloma & Transplant Program, Seattle, WA USA

[17] Karyopharm Therapeut, Newton, MA USA

[18] Univ Nebraska Med Ctr, Div Hematol Oncol, Omaha, NE USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-124370

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3165

引用

页数：4

共 50 条

[1] Selinexor, Lenalidomide and Dexamethasone (SRd) for Patients with Relapsed/Refractory and Newly Diagnosed Multiple Myeloma
White, Darrell J.
LeBlanc, Richard
Baljevic, Muhamed
Bahlis, Nizar J.
Lentzsch, Suzanne
Venner, Christopher P.
Gasparetto, Cristina
Chen, Christine I.
Lipe, Brea
Tuchman, Sascha A.
Sutherland, Heather J.
Kotb, Rami
Sebag, Michael
Callander, Natalie S.
Bensinger, William I.
Rossi, Adriana C.
Sheehan, Heidi
Van Domelen, Dane
Zhou, Tianjun
Kazuharu, Kai
Shah, Jatin
Shacham, Sharon
Kauffman, Michael G.
Schiller, Gary J.
[J]. BLOOD, 2020, 136
[2] Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
White, Darrell
LeBlanc, Richard
Venner, Chritopher
Bahlis, Nizar J.
Lentzsch, Suzanne
Gasparetto, Cristina J.
Chen, Christine
Lipe, Brea
Sutherland, Heather
Tuchman, Sascha
Baljevic, Muhamed
Kotb, Rami
Sebag, Michael
Callander, Nancy
Bensinger, William
Kai, Kazuharu
Liu, Jianjun
Sheehan, Heidi
Estepan, Daniel Nova
Shah, Jatin
Schiller, Gary J.
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E55 - E55
[3] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
Richardson, Paul G.
Weller, Edie
Lonial, Sagar
Jakubowiak, Andrzej J.
Jagannath, Sundar
Raje, Noopur S.
Avigan, David E.
Xie, Wanling
Ghobrial, Irene M.
Schlossman, Robert L.
Mazumder, Amitabha
Munshi, Nikhil C.
Vesole, David H.
Joyce, Robin
Kaufman, Jonathan L.
Doss, Deborah
Warren, Diane L.
Lunde, Laura E.
Kaster, Sarah
DeLaney, Carol
Hideshima, Teru
Mitsiades, Constantine S.
Knight, Robert
Esseltine, Dixie-Lee
Anderson, Kenneth C.
[J]. BLOOD, 2010, 116 (05) : 679 - 686
[4] Efficacy and safety of thalidomide and dexamethasone combination with or without cyclophosphamide in patients with newly diagnosed multiple myeloma
Kim, Y.-K.
Lee, J. J.
Sohn, S. K.
Shin, H. J.
Lee, S. R.
Shim, H. J.
Ahn, J. S.
Kim, D. H.
Yang, D. H.
Cho, S. H.
Chung, I. J.
Kim, H. J.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 411 - 412
[5] SAFETY AND EFFICACY OF LENALIDOMIDE PLUS DEXAMETHASONE IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS 70 YEARS OF AGE AND OLDER
Gay, F.
Hayman, S.
Buadi, F.
Detweiler-Short, K.
Lacy, M.
Kumar, S.
Dispenzieri, A.
Gertz, M.
Rajkumar, V.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 153 - 153
[6] The efficacy and safety of modified bortezomib-lenalidomide-dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma
Okazuka, Kiyoshi
Ishida, Tadao
Nashimoto, Junichiro
Uto, Yui
Sato, Kota
Miyazaki, Kanji
Ogura, Mizuki
Yoshiki, Yumiko
Abe, Yu
Tsukada, Nobuhiro
Suzuki, Kenshi
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (02) : 110 - 115
[7] Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma
Richardson, Paul G.
Hofmeister, Craig C.
Rosenbaum, Cara A.
Htut, Myo
Vesole, David H.
Berdeja, Jesus G.
Liedtke, Michaela
Chari, Ajai
Smith, Stephen D.
Lebovic, Daniel
Raje, Noopur
Byrne, Catriona
Liao, Eileen
Gupta, Neeraj
Di Bacco, Alessandra
Estevam, Jose
Berg, Deborah
Baz, Rachid
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (02) : 231 - 244
[8] Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Jakubowiak, Andrzej
Usmani, Saad Z.
Krishnan, Amrita
Lonial, Sagar
Comenzo, Raymond L.
Wang, Jianping
de Boer, Carla
Deraedt, William
Weiss, Brendan M.
Schecter, Jordan M.
Chari, Ajai
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (10): : 701 - 710
[9] Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
Kumar, Shaji K.
Kapoor, Prashant
Laplant, Betsy
Phuong-Dung, Liang
Muchtar, Eli
Buadi, Francis K.
Gonsalves, Wilson I.
Malave, Gabriella C.
Vossen, Alanna M.
Dingli, David
Go, Ronald S.
Warsame, Rahma M.
Kourelis, Taxiarchis
Hwa, Yi L.
Fonder, Amie
Hobbs, Miriam A.
Lust, John A.
Lacy, Martha Q.
Dispenzieri, Angela
Hayman, Suzanne R.
Leung, Nelson
Rajkumar, S. Vincent
Gertz, Morie A.
[J]. BLOOD, 2020, 136
[10] Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone
Loncharich, Alexa J.
Fiala, Mark A.
Slade, Michael J.
Vickroy, Angela
Kavanaugh, Margaret
Wilson, Carmen
Schroeder, Mark A.
Stockerl-Goldstein, Keith
Vij, Ravi
Sanfilippo, Kristen M.
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : 825 - 828

← 1 2 3 4 5 →